-
Mashup Score: 6FDA Update: Agency Approves Abbott TriClip to Treat TR - American College of Cardiology - 1 month(s) ago
The U.S. Food and Drug Administration has approved on April 2 the Abbott TriClip ™, a transcatheter edge-to-edge repair (TEER) system specifically designed for the treatment of tricuspid regurgitation (TR), according to an Abbott press release. The first-of-its-kind device provides a minimally invasive treatment option for patients in need of tricuspid valve repair. Before approving the device, the FDA reviewed results from the TRILUMINATE Pivotal trial, presented at ACC.23/WCC, which found that tricuspid
Source: www.acc.orgCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 2Contrast-Sparing Intravascular Ultrasound–Guided Caval Valve Implantation for Severe Symptomatic Tricuspid Regurgitation: - 7 month(s) ago
Abstract Patients with severe tricuspid regurgitation and right ventricular dysfunction have limited therapeutic options due to anatomic complexity, advanced disease at presentation, and comorbidit…
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 3Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter Treatment - 7 month(s) ago
Abstract Background Although tricuspid transcatheter edge-to-edge repair (TEER) has been suggested to improve outcomes in patients with tricuspid regurgitation (TR), patients remain at substantial …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 2
Comparing the guidelines is useful and “often leads to some further fine-tuning down the road,” says Robert Bonow.
Source: www.tctmd.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 10Burden of Undiagnosed Valvular Heart Disease in the Elderly in the Community: Heart of New Ulm Valve Study - 9 month(s) ago
∗Minneapolis Heart Institute at Abbott Northwestern Hospital, Allina Health, 920 East 28th Street, Suite 300, Minneapolis, Minnesota 55407, USA. E-mail: E-mail Address: [email protected] Copyright © 2023, American College of Cardiology Foundation. Published by Elsevier Published online April 12,
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Cardiologists detail world's first use of new annuloplasty system for tricuspid regurgitation - 10 month(s) ago
Early data suggest the new transcatheter tricuspid valve repair device could make a big impact on patient care, but additional research is still necessary.
Source: cardiovascularbusiness.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
In older patients with severe or worse tricuspid regurgitation, a tricuspid transcatheter edge-to-edge repair system was safe and improved tricuspid regurgitation grade and quality of life measures for the sickest patients, data show. Philipp Lurz, MD, PhD, professor and deputy head of cardiology, Heart Center Leipzig at University of Leipzig, Germany, presented findings from the bRIGHT
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
For adults with severe or greater tricuspid regurgitation, use of a novel transcatheter tricuspid valve replacement system was associated with high procedural success, symptomatic improvement and survival at 2 years, researchers reported.The findings were presented at EuroPCR and simultaneously published in the Journal of the American College of Cardiology.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Clinical Solutions for Everyday Practice
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
Procedural Intervention in Valve Disease
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dr. @psorajja addresses gaps in percutaneous management of #vhdTR: “Diagnostic and therapeutic imagine expertise is limited, even in experienced centers.” https://t.co/V7bjEiSmd1 #TransformCVCare #cvVHD https://t.co/fJG3qPeSuq
-
FDA Update: @US_FDA has approved the Abbott TriClip, a TEER system specifically designed to treat #vhdTR, after reviewing findings from the TRILUMINATE Pivotal trial. Learn more: https://t.co/MVAuQaTPLc